259322001: Pancreatic lipase (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Enzyme\...

\Pancreatic enzyme (substance)\Pancreatic lipase

\Hydrolase\Triacylglycerol lipase\Pancreatic lipase

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Polypeptide\Protein\Triacylglycerol lipase\Pancreatic lipase

\Organic compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Polypeptide\Protein\Triacylglycerol lipase\Pancreatic lipase

\Biological substance\Protein and/or protein derivative\Protein\Triacylglycerol lipase\Pancreatic lipase
\Biological substance\Polypeptide\Protein\Triacylglycerol lipase\Pancreatic lipase

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

386184016 Pancreatic lipase en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

650855015 Pancreatic lipase (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Pancreatic lipase	Is a	Lipase	false	Inferred relationship	Some
Pancreatic lipase	Is a	Triacylglycerol lipase	true	Inferred relationship	Some
Pancreatic lipase	Is a	Pancreatic enzyme (substance)	true	Inferred relationship	Some
Pancreatic lipase	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Hydrolase (disposition)	true	Inferred relationship	Some
Pancreatic lipase	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Pancreatic enzyme (disposition)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing amylase and endopeptidase and pancreatic lipase (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Pancreatic lipase	Inferred relationship	Some	2
Product containing amylase and endopeptidase and pancreatic lipase in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Pancreatic lipase	Inferred relationship	Some	2
Amylase and endopeptidase and pancreatic lipase only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Pancreatic lipase	Inferred relationship	Some	2
Product containing precisely amylase 20000 unit and endopeptidase 25000 unit and pancreatic lipase 4500 unit/1 each conventional release oral capsule (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Pancreatic lipase	Inferred relationship	Some	2
Product containing precisely amylase 20000 unit and endopeptidase 25000 unit and pancreatic lipase 4500 unit/1 each conventional release oral capsule (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Pancreatic lipase	Inferred relationship	Some	2
Product containing only amylase and endopeptidase and pancreatic lipase (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Pancreatic lipase	Inferred relationship	Some	2
Product containing precisely pancreatic amylase 8000 unit and pancreatic lipase 10000 unit and pancreatic protease 600 unit/1 each gastro-resistant oral capsule (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Pancreatic lipase	Inferred relationship	Some	2
Product containing precisely pancreatic amylase 8000 unit and pancreatic lipase 10000 unit and pancreatic protease 600 unit/1 each gastro-resistant oral capsule (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Pancreatic lipase	Inferred relationship	Some	2
Product containing precisely pancreatic amylase 18000 unit and pancreatic lipase 25000 unit and pancreatic protease 1000 unit/1 each gastro-resistant oral capsule (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Pancreatic lipase	Inferred relationship	Some	2
Product containing precisely pancreatic amylase 18000 unit and pancreatic lipase 25000 unit and pancreatic protease 1000 unit/1 each gastro-resistant oral capsule (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Pancreatic lipase	Inferred relationship	Some	2
Pancreatic amylase and pancreatic lipase and pancreatic protease only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Pancreatic lipase	Inferred relationship	Some	2
Pancreatic amylase and pancreatic lipase and pancreatic protease only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Pancreatic lipase	Inferred relationship	Some	2
Product containing pancreatic amylase and pancreatic lipase and pancreatic protease in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Pancreatic lipase	Inferred relationship	Some	2
Pancreatic amylase- and pancreatic lipase- and pancreatic protease-containing product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Pancreatic lipase	Inferred relationship	Some	2
Product containing precisely pancreatic amylase 36 unit/1 milligram and pancreatic lipase 50 unit/1 milligram and pancreatic protease 2 unit/1 milligram gastro-resistant oral granules (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Pancreatic lipase	Inferred relationship	Some	2
Product containing precisely pancreatic amylase 36 unit/1 milligram and pancreatic lipase 50 unit/1 milligram and pancreatic protease 2 unit/1 milligram gastro-resistant oral granules (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Pancreatic lipase	Inferred relationship	Some	2
Pancreatic amylase 16000 unit and pancreatic lipase 20000 unit and pancreatic protease 1200 unit gastro-resistant oral capsule	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Pancreatic lipase	Inferred relationship	Some	2
Pancreatic amylase 16000 unit and pancreatic lipase 20000 unit and pancreatic protease 1200 unit gastro-resistant oral capsule	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Pancreatic lipase	Inferred relationship	Some	2

Reference Sets